The rejection of Acomplia doesn’t make crusader Steven Nissen look good:
That means it’s at least the second time in under a year that Steven Nissen has been wrong about the promise of new drugs. Nissen, of course, is the well-known Cleveland Clinic cardiologist whose efforts were largely responsible for toppling Vioxx, and he just co-authored a NEJM study raising serious doubts about Avandia.
He was also optimistic about Pfizer-dud torcetrapib. (via WSJ Health Blog)
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
